Citation

Javier Chinen, William T. Shearer. Gene Therapy for Pediatric HIV Infection. The Immunologist. 1997 Jan 01; 5(3):93-7.

Citation

Ann J. Melvin, MD, Lisa M. Frenkel, MD. Pediatric HIV-1 Infection. Obstetrics and Gynecology Clinics of North America. 1997 Dec 01; 24(4):911- 924.

Citation

M. Shinkai, Sam Bozzette, M.D., Ph.D., William G. Powderly, M.D., Peter T. Frame, M.D., Stephen A. Spector, M.D. Utility of urine and leukocyte cultures and plasma DNA polymerase chain reaction for identification of AIDS patients at risk for developing human cytomegalovirus disease. Journal of Infectious Diseases. 1997 Feb 01; 175(2):302-8.

Citation

Sophie Pueyo, L. R. Salmi, Genevieve Chene, Catherine Leport, M.D., Philippe Morlat, M.D., L. Dequae, V. Gregoire, Richard Hafner, M.D., Jean-Louis Vilde, Benjamin J. Luft, M.D., Jean Aubertin, Roger Salamon. Survival after AIDS-defining events in patients with 200 lymphocytes CD4+ x 10(6)/L who are toxoplasmosis antibody positive. ANRS 005/ACTG 154 Trial Group. Journal of Acquired Immune Deficiency Syndromes. 1997 Apr 15; 14(5):459-64.

Citation

Robert Zackin, Sc.D., Lee-Jen Wei, Ph.D. Analysis of repeated virological measurements based on cell dilution assays. Statistics In Medicine. 1997 Mar 15; 16(5):571-82.

Citation

Albert W. Wu, M.D., M.P.H., Ron D. Hays, Ph.D., Sue Kelly, B.A., F. Malitz, Sam Bozzette, M.D., Ph.D. Applications of the Medical Outcomes Study health-related quality of life measures in HIV/AIDS. Quality of Life Research. 1997 Aug 01; 6(6):531-4.

Citation

Ross E. McKinney, Jr., M.D. Randomized Study of the Tolerance and Efficacy of High Versus Low Dose Zidovudine in HIV-Infected Children with Mild to Moderate Symptoms (ACTG 128). Journal of Infectious Diseases. 1996 May 01; 173(May):1097-1106.

Citation

Sam Bozzette, M.D., Ph.D., David Kanouse, Ph.D., Naihua Duan, Ph.D., Sandra H. Berry, M.A., Douglas D. Richman, M.D. The impact of zidovudine compared with didanosine on health status and functioning in persons with advanced HIV infection and a varying duration of prior zidovudine therapy. AIDS Clinical Trials Group 116/117 Study Group. Antiviral Therapy. 1996 Jan 01; 1(1):21-32.

Citation

Rhoda S. Sperling, David E. Shapiro, Robert W. Coombs, John A. Todd, Steven A. Herman, George D. McSherry, Mary Jo O'Sullivan, Russell B. Van Dyke, Eleanor Jimenez, Christine Rouzioux, Patricia M. Flynn, John L. Sullivan. Maternal Viral Load, Zidovudine Treatment, and the Risk of Transmission of Human Immunodeficiency Virus Type 1 From Mother To Infant. New England Journal of Medicine. 1996 Nov 28; 335(22):1621-9.

Citation

Diane V. Havlir, MD, Douglas D. Richman, MD. Viral dynamics of HIV: implications for drug development and therapeutic strategies. Annals of Internal Medicine. 1996 Jun 01; 124(11):984-94.